A severe oxaliplatin immune-induced syndrome after oxaliplatin-based pressurized intraperitoneal aerosol chemotherapy (PIPAC)

OBJECTIVES: Oxaliplatin immune-induced syndrome (OIIS) was recently recognized as an uncommon complication of oxaliplatin therapy. METHODS: We report an exceptionally OIIS after pressurized intraperitoneal aerosol chemotherapy (PIPAC). RESULTS: Our patient developed a severe OIIS probably related to...

Descripción completa

Detalles Bibliográficos
Autores principales: Ezanno, Anne-Cecile, Malgras, Brice, Aoun, Olivier, Delarge, Amaury, Doreille, Alice, Pocard, Marc
Formato: Online Artículo Texto
Lenguaje:English
Publicado: De Gruyter 2022
Materias:
Short Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9069496/
https://www.ncbi.nlm.nih.gov/pubmed/35602921
http://dx.doi.org/10.1515/pp-2021-0138

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9069496/
https://www.ncbi.nlm.nih.gov/pubmed/35602921
http://dx.doi.org/10.1515/pp-2021-0138

Ejemplares similares